Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
460.28
-18.20 (-3.80%)
At close: Nov 5, 2026, 4:00 PM EST
449.98
-10.30 (-2.24%)
Pre-market: Nov 6, 2026, 8:21 AM EST

Amgen Revenue

Amgen had revenue of $10.37B in the quarter ending September 30, 2026, with 8.45% growth. This brings the company's total for the last twelve months to $38.90B, up 8.15% year-over-year. In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth. That makes Amgen the 355th largest company in the world by revenue and 125th in the United States.

Revenue (ttm)
$38.90B
Revenue Growth
+8.15%
P/S Ratio
6.40
Revenue / Employee
$1,235,016
Employees
31,500
Market Cap
248.97B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Other Products 7.26B 19.8%
  • Prolia 4.41B 12.0%
  • Repatha 3.02B 8.2%
  • Otezla 2.27B 6.2%
  • ENBREL 2.23B 6.1%
  • EVENITY 2.10B 5.7%
  • XGEVA 2.08B 5.7%
  • Other 13.38B 36.4%

By Geography

Chart
  • U.S. 26.42B 71.9%
  • Rest of World (ROW) 10.33B 28.1%
Fiscal year ended Dec 31, 2025 See the full Amgen breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.75B3.33B9.95%
Dec 31, 202433.42B5.23B18.57%
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 201823.75B898.00M3.93%
Dec 31, 201722.85B-142.00M-0.62%
Dec 31, 201622.99B1.33B6.14%
Dec 31, 201521.66B1.60B7.97%
Dec 31, 201420.06B1.39B7.43%
Dec 31, 201318.68B1.41B8.17%
Dec 31, 201217.27B1.68B10.80%
Dec 31, 201115.58B529.00M3.51%
Dec 31, 201015.05B411.00M2.81%
Dec 31, 200914.64B-361.00M-2.41%
Dec 31, 200815.00B232.00M1.57%
Dec 31, 200714.77B503.00M3.53%
Dec 31, 200614.27B1.84B14.79%
Dec 31, 200512.43B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson99.34B
Merck & Co.67.38B
AbbVie66.01B
Pfizer63.63B
AstraZeneca62.38B
Sanofi57.89B
Novartis AG57.36B
Novo Nordisk50.34B
Revenue Rankings